drug-claims

Substrate placeholder — needs review

U.S. Judge Rejects Bayer's Bid to Block Johnson & Johnson Prostate Cancer Drug Claims

A U.S. judge has rejected Bayer's attempt to prevent Johnson & Johnson from making certain claims about its prostate cancer drug. The ruling allows Johnson & Johnson to continue its promotional statements. Details of the decision were reported by Reuters.